Adverse risk increase

Intakes that exceed the ADI will not necessarily result in any adverse effect because the uncertainty factors are designed to be conservative. In practice it is probable that most people could exceed the ADI by a considerable margin before suffering any harm. Nevertheless, the probability that an individual will suffer harm (risk) increases once the ADI is exceeded and so this must be balanced against the costs of control. Conversely, the level of risk below the ADI is never quite zero because there is always a residual risk that relates to the lack of absolute certainty in the methods used for toxicological testing. In some cases no adverse end-point can be identified, such as for many naturally-occurring compounds that are widespread in foods. In such cases an ADI Not Specified (ADI NS) is allocated. 

It should be noted that MOS ratios are no absolute measure of risks. Nobody knows the real risks of chemicals where the exposure exceeds the derived no-effect level (DNEL). The risk assessor only knows that the likelihood of adverse effects increases when the DNEL/E ratios decrease or the E/DNEL ratios increase. Thus, such ratios are internationally accepted only as substitutes for risks. 

Geriatric Considerations - Summary Increased risk of side effects in patients with CVD and hepatic dysfunction. Theophylline has a narrow therapeutic index and is associated with numerous drug interactions. Target serum concentrations are 5-20 mg/L, with adverse effects increasing between 15-20 mg/L. Hepatic metabolism and renal excretion declines with age and the half-life of theophylline increases by 3 to 9 hours in older adults. Smoking induces theophylline metabolism therefore, if a pa-tienf sfops smoking, empiric dosage reduction may be indicated and follow serum concenfrafions closely. 

Between 1980 and 1991, only a few published studies examined the safety and the hypnotic efficacy of the 0.125-mg dose of triazolam in elderly patients ( 318, 319, 320, 321, 322, 323 and 324). These studies and case reports indicate that with continued use, the initial efficacy of the 0.125-mg dose of triazolam in elderly patients begins to wane after 1 week and progressively diminishes to ineffectiveness, usually by the sixth week of continuous administration. During the same period, the risk of potentially serious adverse reactions increases. 

Concurrent use of multiple medications is another major ADR risk factor. The potential for clinically significant drug interactions and additive adverse effects increases as the number of medications in a regimen increases (28, 29). In a study of over 9000 hospital admissions, the strongest predictor of ADRs was the... 

A study of 57 obese women illustrates the use of CT for measuring subcutaneous fat and visceral fat, and the use of the data for predicting adverse risks to health (Zamboni et al 1992), Forty of the women were premenopausal (24-46 years old), while 17 were postmenopausal (52-66 years old). The results (Table 7,1) revealed that the younger obese women tended to have more subcutaneous fat and less visceral fat than the older obese women. The units of area that are used in CT are cm. The data suggest a trend in the aging process of obese women, where there occurs a progressive increase in visceral fat and a reduction in subcutaneous fat-... 

The relative contributions of amoxicillin and clavula-nate to co-amoxiclav-induced hepatotoxicity are incompletely understood. In patients with co-amoxiclav hepatotoxicity, previous use of amoxicillin and rechallenge with amoxicillin were both uneventful, pointing to clavulanic acid as the more likely culprit (16). In a report from the UK, the incidence of liver injury with amoxicillin alone was 0.3 per 10000 prescriptions versus 1.7 with co-amoxiclav (32). The risk increased after multiple use and with increasing age to 1 per 1000 prescriptions of co-amoxiclav. The main message is that the combination should be used with caution in elderly patients. A patient who has had documented hepatotoxicity related to co-amoxiclav should be well informed about this adverse drug reaction and any future use should be prohibited. 

Hyponatremia occurs in an appreciable proportion of patients taking oxcarbazepine (12), perhaps more often than with carbamazepine it is usually asymptomatic. Among 2166 oxcarbazepine-treated patients in the manufacturer s database, the incidence of sodium concentrations below 135 mmol/1 was 22% (13). There was marked hyponatremia (sodium concentrations below 125 mmol/1) in 2.7% overall and the risk increased with age 0% below 6 years, 0.5% 6-17 years, 3.4% at 18-64 years, and 7.3% above 65 years. The incidence of adverse events was similar in all sodium categories the absence of symptoms suggests that the fall in sodium concentrations was not precipitous. 

The potential for human and environmental exposure to a pesticide product usually increases in a stepwise fashion as the product proceeds from discovery to commercial use. As pesticide exposure increases, so does the risk of adverse human health or environmental effects. Therefore, EPA s pesticide regulations are phased in as pesticide exposure, and potential risks, increase (Figure 1). 

The therapeutic range is bounded by a plasma concentration below which no dierapeutic effect is likely, and an upper concentration above which the risk of adverse effects increases. As discussed in the text, many serious adverse reactions to antiarrhythmic drugs can occur at dierapeutic concentrations in susceptible individuals. When only an upper limit is cited, a lower limit has not been well defined. Variable generation of active metabolites may furdier complicate die interpretation of plasma concentration data (Chapters 1 Pharmacokinetics The Dynamics of Drug Absorption, Distribution, and Elimination and 5 Principles of Therapeutics). 

UL does not mean that most individuals who consume more than the UL will suffer adverse health effects, but that the risk of adverse effects increases as intake increases above the UL. 

Manifestations (clinical) ain, tenderness, immobility Sequela (the adverse reaction) Increased risk of fractures... 

Prevention strategies for risk reduction are implemented before a risk event occurs. Reducing the probability of an adverse risk has intrinsic welfare benefits and increases people s expected income and reduces their income variance. Preventive interventions include measures designed to reduce risks in the labor market (the risk of unemployment, for instance), preventive health care measures (such as vaccination, use of mosquito nets, or information campaigns), and the development and implementation of standards (such... 

In additional EPA studies, subchronic inhalation was evaluated ia the rat for 4 and 13 weeks, respectively, and no adverse effects other than nasal irritation were noted. In the above-mentioned NTP chronic toxicity study ia mice, no chronic toxic effects other than those resulting from bronchial irritation were noted. There was no treatment-related increase ia tumors ia male mice, but female mice had a slight increase in bronchial tumors. Neither species had an increase in cancer. Naphthalene showed no biological activity in other chemical carcinogen tests, indicating Htde cancer risk (44). No incidents of chronic effects have been reported as a result of industrial exposure to naphthalene (28,41). 

There are hundreds of topical steroid preparations that are available for the treatment of skin diseases. In addition to their aforementioned antiinflammatory effects, topical steroids also exert their effects by vasoconstriction of the capillaries in the superficial dermis and by reduction of cellular mitosis and cell proliferation especially in the basal cell layer of the skin. In addition to the aforementioned systemic side effects, topical steroids can have adverse local effects. Chronic treatment with topical corticosteroids may increase the risk of bacterial and fungal infections. A combination steroid and antibacterial agent can be used to combat this problem. Additional local side effects that can be caused by extended use of topical steroids are epidermal atrophy, acne, glaucoma and cataracts (thus the weakest concentrations should be used in and around the eyes), pigmentation problems, hypertrichosis, allergic contact dermatitis, perioral dermatitis, and granuloma gluteale infantum (251). 

Although immediate reactions of anaphylaxis, bronchospasm, and urticaria have been reported, most commonly patients exhibiting an adverse reaction develop a maculopapular rash, usually after several days of therapy. They may also develop fever and eosinophilia (80,219). Cefoperazone (34) and ceftriaxone (39), having greater biUary excretion than other cephalosporins, are associated with an increased risk of diarrhea, which may be caused by selection of cytotoxin producing stains of Clostridium difficile (219). 

In adults, a few areas may require further study. For example, there is a report of soya consumption causing an increased incidence of hyperplastic epithelial cells in the nipple aspirate fluid of pre- and postmenopausal women.This could constitute a risk factor for breast cancer. Also, the use in herbal medicine of particular plants emphasises that these species have the potential to cause physiological changes. Consequently, the increasing public interest in the use of herbal medicines could lead to unintended (adverse) effects, particularly as most... 

---